No-show for treatment in substance abuse patients with comorbid symptomatology: Validity results from a controlled trial of the ASAM patient placement criteria

Journal of Addiction Medicine

Volumn 1, Issue 2, 2007, Pages 79-87

  Angarita, Gustavo A ^a,b   Reif, Sharon ^c   Pirard, Sandrine ^a,d   Lee, Sang ^a   Sharon, Estee ^a   Gastfriend, David R ^a,e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRANDEIS UNIVERSITY   (United States)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e ALKERMES INC   (United States)

Author keywords

Asam levels of care; Co occurring disorders; No shows; Substance use disorder; Treatment matching criteria

Indexed keywords

EID: 84870661854     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0b013e3180634c1d     Document Type: Article

References (37)

1. Drake RE, Esoock SM, Shanner A, et al. Implementing dual diagnosis services for clients with severe mental illness. Psychiatric Serv. 2001; 52:469-76.
2. Kessler RC, Kessler CB, Nelson KA, et al. The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry. 1996;66:17-31.
3. Kessler RC. The epidemiology of dual diagnosis. Biol Psychiatry. 2004;56:730-7.
4. Rubin A, Gastfriend DR. Patient placement criteria and their relation to access to appropriate level of care and engagement in alcoholism treatment. Recent Dev Alcohol. 2001;15:157-176.
5. Dodge R, Sindelar J, Sinha R. The role of depression symptoms in predicting drug abstinence in outpatient substance abuse treatment. J Subst Abuse Treat. 2005;28:189-96.
6. Gouzoulis-Mayfrank E. Dual diagnosis of psychosis and addiction. From principles to practice. Der Nervenarzt. 2004;75:642-50.
7. Tsuang J, Fong TW. Treatment of patients with schizophrenia and substance abuse disorders. Curr Pharm Des. 2004;10:2249-61.
8. Brady TM, Krebs CP, Laird G. Psychiatric comorbidity and not completing jail-based substance abuse treatment. Am J Addict. 2004;13:83-101.
9. Timko C, Dixon K, Moos RH. Treatment for dual diagnosis patients in the psychiatric and substance abuse systems. Ment Health Serv Res. 2005;7:229-42.
10. Minkoff K. Comprehensive Continuous Integrated System of Care (CCISC) psychopharmacology practice guidelines for individuals with co-occurring psychiatric and substance use disorders (COD). Available at: http://www.kenminkoff.com/article1.html. Accessed June 9, 2005.
11. Hoffmann N, Halikas J, Mee-Lee D et al. American Society of Addiction Medicine Patient Placement Criteria for the Treatment of Psychoactive Substance Use Disorders. Washington, DC: American Society of Addiction Medicine; 1991.
12. Turner WM, Turner KH, Reif S, et al. Feasibility of multidimensional substance abuse treatment matching: Automating the ASAM Patient Placement Criteria. Drug Alcohol Depend. 1999;55:35-43.
13. Baker SL, Gastfriend DR. Reliability of multidimensional substance abuse treatment matching: Implementing the ASAM Patient Placement Criteria. J Addict Dis. 2003;22:45-60.
14. Lefebvre RS, Sharon E, Lee S et al. Concurrent Validity of the ASAM Criteria in Heroin Users [abstract]. Harvard Department of Psychiatry Research Day, Boston, MA, March 2004.
15. Kang SK, Sharon E, Pirard S et al. Presentation: Preference for Residential Rehabilitation in High Frequency Cocaine Dependence: Validation of the American Society of Addiction Medicine (ASAM) Criteria. World Forum of Drugs and Dependencies, Montreal CN, 2002.
16. Reggers J, Ansseau M, Gustin F, et al. Adaptation and validation of the ASAM PPC-2R criteria in French and Dutch speaking Belgian drugaddicts. Presented at the College on Problems of Drug Dependence, Miami FL, 2003.
17. Magura S, Staines G, Kosanke N, et al. Predictive validity of the ASAM patient placement criteria for naturalistically matched vs. mismatched alcoholism patients. J Addict Dis. 2003;22:149-164.
18. Sharon E, Krebs C, Turner W, et al. Predictive validity of the ASAM patient placement criteria for hospital utilization. J Addict Dis. 2003;22: 79-93.
19. Timko C, Lesar M, Engelbrekt M, et al. Changes in services and structure in community residential treatment facilities for substance abuse patients, Psychiatr Serv. 2000;51:494-8.
20. Johnson A, Gastfriend DR. Use of ASAM PPC: Data from a national sample of Addiction Treatment Programs. Presented at the American Society of Addiction Medicine Annual Medical-Scientific Conference, Dallas TX, 2005.
21. Gastfriend DR, Lu SH, Sharon E. Placement matching: challenges and technical progress. Substance Use Misuse. 2000;35:2191-213.
22. McLellan AT, Kushner H, Metzger M, et al. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat. 1992;9:199-213.
23. Najavits LM, Gastfriend DR, Nakayama EY, et al. A measure of readiness for substance abuse treatment: psychometric properties of the RAATE research interview. Am J Addict. 1997;6:74-82.
24. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
25. Makela K. Studies of the reliability and validity of the Addiction Severity Index. Addiction. 2004;99:398-418.
26. O'Sullivan R, Fava M, Augustan C, et al. Sensitivity of the 6 item Hamilton depression rating scale. Acta Psychiatrica Scand. 1997;95: 379-84.
27. Greenfield SF. Women and alcohol use disorders. Harvard Rev Psychiatry. 2002;10:76-85.
28. Avants SK, Margolin A, Kosten TR, et al. When is less treatment better? The role of social anxiety in matching methadone patients to psychosocial treatments. J Consult Clin Psychol. 1998;66:924-31.
29. Andrews DA, Bonta J. The Psychology of Criminal Conduct. Cincinnati, OH: Anderson Publishing, 1998.
30. Joe GW, Simpson DD, Hubbard RL. Unmet service needs in methadone maintenance. Int J Addict. 1991;26:1-22.
31. McLellan AT, Hagan TA, Meyers K, et al. "Intensive" outpatient substance abuse treatment: comparisons with "traditional" outpatient treatment. J Addict Dis. 1997;16:57-84.
32. Weisner C, Schmidt L. Gender disparities in treatment for alcohol problems. J Am Med Assoc. 1992;268:1872-6.
33. Grella CE. Effects of gender and diagnosis on addiction history, treatment utilization, and psychosocial functioning among a dually-diagnosed sample in drug treatment. J Psychoactive Drugs. 2003;35 (Suppl): 169-79.
34. Grant BF, Stinson FS, Dawson DA, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61:807-16.
35. Grant BF, Hasin DS, Blanco C, et al. The epidemiology of social anxiety disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2005;66: 1351-61.
36. Vaillant GE. What can long-term follow-up teach us about relapse and prevention of relapse in addiction? Br J Addict. 1988;83:1147-57.
37. Gastfriend DR, McLellan AT. Treatment matching: theoretic basis and practical implications. Med Clin North Am. 1997;81:945-66.